{"id":340230,"date":"2025-08-20T10:53:57","date_gmt":"2025-08-20T10:53:57","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-geron-corporation\/"},"modified":"2025-08-20T10:53:57","modified_gmt":"2025-08-20T10:53:57","slug":"how-to-buy-geron-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/","title":{"rendered":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Geron Corporation (GERN) hisselerini g\u00fcncel fiyat\u0131 $1.44 ile nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenin. Bu biyoteknoloji hissesi i\u00e7in yat\u0131r\u0131m stratejilerini, riskleri ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Geron Corporation (GERN) hisselerini g\u00fcncel fiyat\u0131 $1.44 ile nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenin. Bu biyoteknoloji hissesi i\u00e7in yat\u0131r\u0131m stratejilerini, riskleri ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Kanser tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Geron Corporation (GERN), y\u00fcksek b\u00fcy\u00fcme potansiyeline sahip hisselere bakan yat\u0131r\u0131mc\u0131lar i\u00e7in heyecan verici bir f\u0131rsat sunuyor. \u00c7\u0131\u011f\u0131r a\u00e7an RYTELO tedavileri ilgi g\u00f6r\u00fcrken, bu t\u0131bbi bir at\u0131l\u0131m hikayesine erken dahil olma \u015fans\u0131n\u0131z olabilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kanser tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Geron Corporation (GERN), y\u00fcksek b\u00fcy\u00fcme potansiyeline sahip hisselere bakan yat\u0131r\u0131mc\u0131lar i\u00e7in heyecan verici bir f\u0131rsat sunuyor. \u00c7\u0131\u011f\u0131r a\u00e7an RYTELO tedavileri ilgi g\u00f6r\u00fcrken, bu t\u0131bbi bir at\u0131l\u0131m hikayesine erken dahil olma \u015fans\u0131n\u0131z olabilir."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Fiyat\u0131 ve Piyasa Konumu<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla Geron Corporation (GERN) hisseleri <strong>1,44 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong>, GERN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kritik bir tarih. \u015eirketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn ve ge\u00e7mi\u015f deneyimler bu duyurular\u0131n hisse senedini \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebilece\u011fini g\u00f6steriyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 GERN Hisselerini Nas\u0131l Etkiler?<\/h3> <p>6 A\u011fustos 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131 de\u011ferli bilgiler sunuyor. \u015eirket, <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250806535408\/en\/Geron-Corporation-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Business-Highlights\">49 milyon $ gelirle m\u00fckemmel 2. \u00e7eyrek sonu\u00e7lar\u0131<\/a> bildirdi ve bu %24\u2019l\u00fck \u00e7eyreklik art\u0131\u015f\u0131 temsil ediyor. Bu olumlu haberin ard\u0131ndan, 13 A\u011fustos\u2019ta hisse senedi %7,37 y\u00fckseldi; yat\u0131r\u0131mc\u0131lar RYTELO tedavisinin g\u00fc\u00e7l\u00fc ticari performans\u0131n\u0131 sindirdi.<\/p> <p>Tarihsel olarak GERN, klinik deneme g\u00fcncellemeleri ve d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na g\u00fc\u00e7l\u00fc tepki veriyor. \u015eirket bu y\u0131l\u0131n ba\u015flar\u0131nda RYTELO i\u00e7in AB onay\u0131 ald\u0131\u011f\u0131nda, hisse benzer \u015fekilde \u00e7ift haneli y\u00fczdelik hareketler g\u00f6rd\u00fc. Yat\u0131r\u0131mc\u0131lar i\u00e7in bu olaylar hem f\u0131rsat hem de risk anlam\u0131na geliyor - volatilite do\u011fru zamanlan\u0131rsa avantaj\u0131n\u0131za \u00e7al\u0131\u015fabilir.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: Duygusal Bir Rollercoaster<\/h3> <p>Geron hisseleri son alt\u0131 ayda duygusal bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 3,09 $ zirvesinden %38,68 y\u0131k\u0131c\u0131 d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>Mart 2025<\/strong>: %9,66 ayl\u0131k d\u00fc\u015f\u00fc\u015fle devam eden bask\u0131<\/li> <li><strong>Nisan 2025<\/strong>: Bir ba\u015fka ac\u0131 verici %20,13 d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>Temmuz 2025<\/strong>: 2025 dip seviyesi, tek g\u00fcnde %3,88 d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>A\u011fustos 2025<\/strong>: 1,44 $ civar\u0131nda stabilizasyon ve son olumlu ivme<\/li> <\/ul> <p>Genel alt\u0131 ayl\u0131k performans, Ocak zirvesinden yakla\u015f\u0131k <strong>%60-70 de\u011fer kayb\u0131<\/strong> g\u00f6steriyor ve bu, 2025\u2019in en volatil biyoteknoloji hikayelerinden biri haline getiriyor. Ancak, son stabilizasyon ve olumlu kazan\u00e7lar en k\u00f6t\u00fcs\u00fcn\u00fcn geride kalm\u0131\u015f olabilece\u011fini g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 1,65-1,85 $ (mevcut seviyelerden %14-28 y\u00fckseli\u015f) \u2192 <strong>TUT<\/strong><br> K\u0131sa vadeli g\u00f6r\u00fcn\u00fcm, son olumlu kazan\u00e7lara ra\u011fmen temkinli kal\u0131yor. Hisse, momentumu s\u00fcrd\u00fcrebilece\u011fini kan\u0131tlamal\u0131.<\/li> <li><strong>2026 Projeksiyonu<\/strong>: 2,00-2,50 $ (%39-74 potansiyel b\u00fcy\u00fcme)<br> RYTELO daha geni\u015f kabul g\u00f6rd\u00fck\u00e7e ve ek klinik veriler ortaya \u00e7\u0131kt\u0131k\u00e7a, analistler kademeli de\u011fer art\u0131\u015f\u0131 bekliyor.<\/li> <li><strong>2028 Tahmini<\/strong>: 2,15-2,40 $ (%50-67 art\u0131\u015f)<br> \u0130stikrarl\u0131 ticari uygulama daha tutarl\u0131 performans sa\u011flayabilir, ancak biyotek volatilitesi devam edecek.<\/li> <li><strong>2030 Uzun Vadeli Hedef<\/strong>: 6,47 $+ (%350+ potansiyel y\u00fckseli\u015f)<br> Klinik denemeler ba\u015far\u0131l\u0131 olursa ve ek endikasyonlar onaylan\u0131rsa, GERN \u00e7ok katl\u0131 getiri sa\u011flayabilir.<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in mevcut seviyeler ilgin\u00e7 bir giri\u015f noktas\u0131 sunuyor. Ancak, bu y\u00fcksek riskli bir biyoteknoloji yat\u0131r\u0131m\u0131d\u0131r ve portf\u00f6y\u00fcn\u00fcz\u00fcn sadece k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 temsil etmelidir.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>K\u00e2rl\u0131l\u0131k endi\u015feleri<\/strong>: -0,13 $ negatif EPS ve -%31,09 \u00f6z sermaye getirisi temel zorluklar\u0131 g\u00f6steriyor<\/li> <li><strong>D\u00fczenleyici engeller<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez ve maliyetli olabilir<\/li> <li><strong>Klinik deneme riskleri<\/strong>: Faz 3 sonu\u00e7lar\u0131 yat\u0131r\u0131mc\u0131lar\u0131 hayal k\u0131r\u0131kl\u0131\u011f\u0131na u\u011fratabilir<\/li> <li><strong>Nakit yak\u0131m\u0131<\/strong>: 2024\u2019te 174 milyon $ zarar, dikkatli sermaye y\u00f6netimi gerektirir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Gelir patlamas\u0131<\/strong>: 237 bin $\u2019dan 77 milyon $\u2019a %32.386 b\u00fcy\u00fcme ticari \u00e7eki\u015fi g\u00f6steriyor<\/li> <li><strong>Liderlik y\u00fckseltmesi<\/strong>: Yeni CEO Harout Semerjian hematoloji uzmanl\u0131\u011f\u0131 getiriyor<\/li> <li><strong>\u00c7ifte onay<\/strong>: RYTELO hem ABD hem de AB pazarlar\u0131nda onayland\u0131<\/li> <li><strong>Pazar geni\u015flemesi<\/strong>: Tedavi benimsenmesi hekimler aras\u0131nda art\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3\u2019\u00fcnden fazlas\u0131n\u0131 GERN gibi y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine haftal\u0131k k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Stop-loss belirleyin<\/strong>: Volatilite nedeniyle %15-20 stop-loss emirleri ile kendinizi koruyun<\/li> <li><strong>Kataliz\u00f6rleri takip edin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve klinik deneme g\u00fcncellemelerini izleyin<\/li> <\/ol> <p>Espiri: \"GERN ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - inan\u0131lmaz heyecan verici potansiyel, ama duygusal \u00e7alkant\u0131lara ve ara s\u0131ra laboratuvar patlamalar\u0131na haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>\u2705 Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table border=\"1\" cellpadding=\"5\" cellspacing=\"0\"> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir ticaret platformu se\u00e7in<\/td> <td>NASDAQ listeleri ve biyotek hisseleri sunmas\u0131na dikkat edin<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td> <td>\u00c7o\u011fu platform kimlik ve temel finansal bilgi ister<\/td> <\/tr> <tr> <td>3<\/td> <td>Fon yat\u0131r\u0131n<\/td> <td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>\"GERN\" aramas\u0131 yap\u0131n<\/td> <td>\u015eirket ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td> <td>Limit emirleri volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmeye yard\u0131mc\u0131 olur<\/td> <\/tr> <tr> <td>6<\/td> <td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td> <td>Komisyon ve ek \u00fccretleri kontrol edin<\/td> <\/tr> <tr> <td>7<\/td> <td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td> <td>\u0130stedi\u011finiz fiyat noktas\u0131ndan sat\u0131n ald\u0131\u011f\u0131n\u0131zdan emin olun<\/td> <\/tr> <tr> <td>8<\/td> <td>Fiyat uyar\u0131lar\u0131 kurun<\/td> <td>\u00d6nemli fiyat hareketlerini otomatik olarak takip edin<\/td> <\/tr> <tr> <td>9<\/td> <td>Performans\u0131 takip edin<\/td> <td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 izlemek i\u00e7in portf\u00f6y takip ara\u00e7lar\u0131n\u0131 kullan\u0131n<\/td> <\/tr> <tr> <td>10<\/td> <td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td> <td>K\u00e2r alaca\u011f\u0131n\u0131z veya zarar kesece\u011finiz zaman\u0131 \u00f6nceden belirleyin<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option, GERN ticareti a\u00e7\u0131s\u0131ndan mant\u0131kl\u0131 birka\u00e7 avantaj sunuyor:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - K\u00fc\u00e7\u00fck pozisyonlarla stratejileri test etmek i\u00e7in ideal<\/li> <li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> - Tek bir belge y\u00fckleyip hemen ticarete ba\u015flayabilirsiniz<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Kripto ve e-c\u00fczdanlar dahil 100\u2019den fazla y\u00f6ntem<\/li> <li><strong>Kullan\u0131c\u0131 dostu aray\u00fcz<\/strong> - Hisse senedi ticaretini \u00f6\u011frenen yeni ba\u015flayanlar i\u00e7in kolay navigasyon<\/li> <\/ul> <p>D\u00fc\u015f\u00fck giri\u015f engeli sayesinde, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n inceliklerini \u00f6\u011frenirken k\u00fc\u00e7\u00fck GERN pozisyonlar\u0131yla deney yapabilirsiniz.<\/p> <h2>\ud83c\udf0d 2025\u2019te Geron: Onkoloji \u0130novasyon Lideri<\/h2> <p>Geron Corporation, telomeraz inhibit\u00f6rl\u00fc\u011f\u00fc teknolojisinde \u00f6nc\u00fc konumda olup, kan kanserleri ve miyeloid bozukluklar i\u00e7in tedaviler geli\u015ftiriyor. Amiral gemisi ilac\u0131 RYTELO, myelodisplastik sendromlu hastalara yard\u0131mc\u0131 olan s\u0131n\u0131f\u0131nda ilk bir yakla\u015f\u0131m\u0131 temsil ediyor.<\/p> <p>\u015eirketin geli\u015ftirme a\u015famas\u0131ndan ticari a\u015famaya ge\u00e7i\u015fi dramatik oldu; gelirleri sadece iki y\u0131lda binlerceden milyonlara f\u0131rlad\u0131. Myelofibrozis alan\u0131ndaki devam eden Faz 3 denemeleri, ek milyar dolarl\u0131k pazar f\u0131rsatlar\u0131n\u0131n kap\u0131s\u0131n\u0131 a\u00e7abilir.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025\u2019te Geron\u2019un ara\u015ft\u0131rma ekibi, telomeraz inhibit\u00f6r teknolojilerinin kanser tedavisinin \u00f6tesinde uygulamalara sahip olabilece\u011fini ke\u015ffetti - erken \u00e7al\u0131\u015fmalar ya\u015fa ba\u011fl\u0131 hastal\u0131klarda potansiyel g\u00f6steriyor ve \u015firketin uzun vadeli perspektifini tamamen de\u011fi\u015ftirebilecek yeni terap\u00f6tik alanlar a\u00e7\u0131yor!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Fiyat\u0131 ve Piyasa Konumu<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla Geron Corporation (GERN) hisseleri <strong>1,44 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong>, GERN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kritik bir tarih. \u015eirketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn ve ge\u00e7mi\u015f deneyimler bu duyurular\u0131n hisse senedini \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebilece\u011fini g\u00f6steriyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 GERN Hisselerini Nas\u0131l Etkiler?<\/h3>\n<p>6 A\u011fustos 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131 de\u011ferli bilgiler sunuyor. \u015eirket, <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250806535408\/en\/Geron-Corporation-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Business-Highlights\">49 milyon $ gelirle m\u00fckemmel 2. \u00e7eyrek sonu\u00e7lar\u0131<\/a> bildirdi ve bu %24\u2019l\u00fck \u00e7eyreklik art\u0131\u015f\u0131 temsil ediyor. Bu olumlu haberin ard\u0131ndan, 13 A\u011fustos\u2019ta hisse senedi %7,37 y\u00fckseldi; yat\u0131r\u0131mc\u0131lar RYTELO tedavisinin g\u00fc\u00e7l\u00fc ticari performans\u0131n\u0131 sindirdi.<\/p>\n<p>Tarihsel olarak GERN, klinik deneme g\u00fcncellemeleri ve d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na g\u00fc\u00e7l\u00fc tepki veriyor. \u015eirket bu y\u0131l\u0131n ba\u015flar\u0131nda RYTELO i\u00e7in AB onay\u0131 ald\u0131\u011f\u0131nda, hisse benzer \u015fekilde \u00e7ift haneli y\u00fczdelik hareketler g\u00f6rd\u00fc. Yat\u0131r\u0131mc\u0131lar i\u00e7in bu olaylar hem f\u0131rsat hem de risk anlam\u0131na geliyor &#8211; volatilite do\u011fru zamanlan\u0131rsa avantaj\u0131n\u0131za \u00e7al\u0131\u015fabilir.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: Duygusal Bir Rollercoaster<\/h3>\n<p>Geron hisseleri son alt\u0131 ayda duygusal bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 3,09 $ zirvesinden %38,68 y\u0131k\u0131c\u0131 d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>Mart 2025<\/strong>: %9,66 ayl\u0131k d\u00fc\u015f\u00fc\u015fle devam eden bask\u0131<\/li>\n<li><strong>Nisan 2025<\/strong>: Bir ba\u015fka ac\u0131 verici %20,13 d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>Temmuz 2025<\/strong>: 2025 dip seviyesi, tek g\u00fcnde %3,88 d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 1,44 $ civar\u0131nda stabilizasyon ve son olumlu ivme<\/li>\n<\/ul>\n<p>Genel alt\u0131 ayl\u0131k performans, Ocak zirvesinden yakla\u015f\u0131k <strong>%60-70 de\u011fer kayb\u0131<\/strong> g\u00f6steriyor ve bu, 2025\u2019in en volatil biyoteknoloji hikayelerinden biri haline getiriyor. Ancak, son stabilizasyon ve olumlu kazan\u00e7lar en k\u00f6t\u00fcs\u00fcn\u00fcn geride kalm\u0131\u015f olabilece\u011fini g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 1,65-1,85 $ (mevcut seviyelerden %14-28 y\u00fckseli\u015f) \u2192 <strong>TUT<\/strong><br \/> K\u0131sa vadeli g\u00f6r\u00fcn\u00fcm, son olumlu kazan\u00e7lara ra\u011fmen temkinli kal\u0131yor. Hisse, momentumu s\u00fcrd\u00fcrebilece\u011fini kan\u0131tlamal\u0131.<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 2,00-2,50 $ (%39-74 potansiyel b\u00fcy\u00fcme)<br \/> RYTELO daha geni\u015f kabul g\u00f6rd\u00fck\u00e7e ve ek klinik veriler ortaya \u00e7\u0131kt\u0131k\u00e7a, analistler kademeli de\u011fer art\u0131\u015f\u0131 bekliyor.<\/li>\n<li><strong>2028 Tahmini<\/strong>: 2,15-2,40 $ (%50-67 art\u0131\u015f)<br \/> \u0130stikrarl\u0131 ticari uygulama daha tutarl\u0131 performans sa\u011flayabilir, ancak biyotek volatilitesi devam edecek.<\/li>\n<li><strong>2030 Uzun Vadeli Hedef<\/strong>: 6,47 $+ (%350+ potansiyel y\u00fckseli\u015f)<br \/> Klinik denemeler ba\u015far\u0131l\u0131 olursa ve ek endikasyonlar onaylan\u0131rsa, GERN \u00e7ok katl\u0131 getiri sa\u011flayabilir.<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in mevcut seviyeler ilgin\u00e7 bir giri\u015f noktas\u0131 sunuyor. Ancak, bu y\u00fcksek riskli bir biyoteknoloji yat\u0131r\u0131m\u0131d\u0131r ve portf\u00f6y\u00fcn\u00fcz\u00fcn sadece k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 temsil etmelidir.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>K\u00e2rl\u0131l\u0131k endi\u015feleri<\/strong>: -0,13 $ negatif EPS ve -%31,09 \u00f6z sermaye getirisi temel zorluklar\u0131 g\u00f6steriyor<\/li>\n<li><strong>D\u00fczenleyici engeller<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez ve maliyetli olabilir<\/li>\n<li><strong>Klinik deneme riskleri<\/strong>: Faz 3 sonu\u00e7lar\u0131 yat\u0131r\u0131mc\u0131lar\u0131 hayal k\u0131r\u0131kl\u0131\u011f\u0131na u\u011fratabilir<\/li>\n<li><strong>Nakit yak\u0131m\u0131<\/strong>: 2024\u2019te 174 milyon $ zarar, dikkatli sermaye y\u00f6netimi gerektirir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Gelir patlamas\u0131<\/strong>: 237 bin $\u2019dan 77 milyon $\u2019a %32.386 b\u00fcy\u00fcme ticari \u00e7eki\u015fi g\u00f6steriyor<\/li>\n<li><strong>Liderlik y\u00fckseltmesi<\/strong>: Yeni CEO Harout Semerjian hematoloji uzmanl\u0131\u011f\u0131 getiriyor<\/li>\n<li><strong>\u00c7ifte onay<\/strong>: RYTELO hem ABD hem de AB pazarlar\u0131nda onayland\u0131<\/li>\n<li><strong>Pazar geni\u015flemesi<\/strong>: Tedavi benimsenmesi hekimler aras\u0131nda art\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3\u2019\u00fcnden fazlas\u0131n\u0131 GERN gibi y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine haftal\u0131k k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Stop-loss belirleyin<\/strong>: Volatilite nedeniyle %15-20 stop-loss emirleri ile kendinizi koruyun<\/li>\n<li><strong>Kataliz\u00f6rleri takip edin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve klinik deneme g\u00fcncellemelerini izleyin<\/li>\n<\/ol>\n<p>Espiri: &#8220;GERN ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; inan\u0131lmaz heyecan verici potansiyel, ama duygusal \u00e7alkant\u0131lara ve ara s\u0131ra laboratuvar patlamalar\u0131na haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>\u2705 Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table border=\"1\" cellpadding=\"5\" cellspacing=\"0\">\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve biyotek hisseleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve temel finansal bilgi ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;GERN&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmeye yard\u0131mc\u0131 olur<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyon ve ek \u00fccretleri kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td>\n<td>\u0130stedi\u011finiz fiyat noktas\u0131ndan sat\u0131n ald\u0131\u011f\u0131n\u0131zdan emin olun<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Fiyat uyar\u0131lar\u0131 kurun<\/td>\n<td>\u00d6nemli fiyat hareketlerini otomatik olarak takip edin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Performans\u0131 takip edin<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 izlemek i\u00e7in portf\u00f6y takip ara\u00e7lar\u0131n\u0131 kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r alaca\u011f\u0131n\u0131z veya zarar kesece\u011finiz zaman\u0131 \u00f6nceden belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option, GERN ticareti a\u00e7\u0131s\u0131ndan mant\u0131kl\u0131 birka\u00e7 avantaj sunuyor:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; K\u00fc\u00e7\u00fck pozisyonlarla stratejileri test etmek i\u00e7in ideal<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; Tek bir belge y\u00fckleyip hemen ticarete ba\u015flayabilirsiniz<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Kripto ve e-c\u00fczdanlar dahil 100\u2019den fazla y\u00f6ntem<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu aray\u00fcz<\/strong> &#8211; Hisse senedi ticaretini \u00f6\u011frenen yeni ba\u015flayanlar i\u00e7in kolay navigasyon<\/li>\n<\/ul>\n<p>D\u00fc\u015f\u00fck giri\u015f engeli sayesinde, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n inceliklerini \u00f6\u011frenirken k\u00fc\u00e7\u00fck GERN pozisyonlar\u0131yla deney yapabilirsiniz.<\/p>\n<h2>\ud83c\udf0d 2025\u2019te Geron: Onkoloji \u0130novasyon Lideri<\/h2>\n<p>Geron Corporation, telomeraz inhibit\u00f6rl\u00fc\u011f\u00fc teknolojisinde \u00f6nc\u00fc konumda olup, kan kanserleri ve miyeloid bozukluklar i\u00e7in tedaviler geli\u015ftiriyor. Amiral gemisi ilac\u0131 RYTELO, myelodisplastik sendromlu hastalara yard\u0131mc\u0131 olan s\u0131n\u0131f\u0131nda ilk bir yakla\u015f\u0131m\u0131 temsil ediyor.<\/p>\n<p>\u015eirketin geli\u015ftirme a\u015famas\u0131ndan ticari a\u015famaya ge\u00e7i\u015fi dramatik oldu; gelirleri sadece iki y\u0131lda binlerceden milyonlara f\u0131rlad\u0131. Myelofibrozis alan\u0131ndaki devam eden Faz 3 denemeleri, ek milyar dolarl\u0131k pazar f\u0131rsatlar\u0131n\u0131n kap\u0131s\u0131n\u0131 a\u00e7abilir.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025\u2019te Geron\u2019un ara\u015ft\u0131rma ekibi, telomeraz inhibit\u00f6r teknolojilerinin kanser tedavisinin \u00f6tesinde uygulamalara sahip olabilece\u011fini ke\u015ffetti &#8211; erken \u00e7al\u0131\u015fmalar ya\u015fa ba\u011fl\u0131 hastal\u0131klarda potansiyel g\u00f6steriyor ve \u015firketin uzun vadeli perspektifini tamamen de\u011fi\u015ftirebilecek yeni terap\u00f6tik alanlar a\u00e7\u0131yor!<\/p>\n"},"faq":[{"question":"Geron Corporation hisseleri nereden al\u0131nabilir?","answer":"Geron Corporation hisseleri NASDAQ borsas\u0131nda \"GERN\" sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Geron Corporation hisseleri almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma g\u00f6re de\u011fi\u015fir. Ancak Pocket Option gibi platformlarda sadece 5 $ depozito ile ba\u015flayabilirsiniz."},{"question":"Geron Corporation hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda negatif k\u00e2rl\u0131l\u0131k, d\u00fczenleyici onay s\u00fcre\u00e7leri, klinik deneme sonu\u00e7lar\u0131 ve y\u00fcksek nakit yak\u0131m\u0131 bulunmaktad\u0131r."},{"question":"Geron Corporation hisseleri i\u00e7in uzun vadeli fiyat hedefi nedir?","answer":"2030 y\u0131l\u0131 i\u00e7in uzun vadeli fiyat hedefi 6,47 $ ve \u00fczeri olarak \u00f6ng\u00f6r\u00fclmekte olup, bu %350\u2019den fazla potansiyel y\u00fckseli\u015f anlam\u0131na gelir."},{"question":"Yeni ba\u015flayan biri Geron hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, dolar maliyeti ortalamas\u0131 yaparak, stop-loss emirleri belirleyerek ve \u00f6nemli haberleri takip ederek yat\u0131r\u0131m yapmas\u0131 \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Geron Corporation hisseleri nereden al\u0131nabilir?","answer":"Geron Corporation hisseleri NASDAQ borsas\u0131nda \"GERN\" sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Geron Corporation hisseleri almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma g\u00f6re de\u011fi\u015fir. Ancak Pocket Option gibi platformlarda sadece 5 $ depozito ile ba\u015flayabilirsiniz."},{"question":"Geron Corporation hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda negatif k\u00e2rl\u0131l\u0131k, d\u00fczenleyici onay s\u00fcre\u00e7leri, klinik deneme sonu\u00e7lar\u0131 ve y\u00fcksek nakit yak\u0131m\u0131 bulunmaktad\u0131r."},{"question":"Geron Corporation hisseleri i\u00e7in uzun vadeli fiyat hedefi nedir?","answer":"2030 y\u0131l\u0131 i\u00e7in uzun vadeli fiyat hedefi 6,47 $ ve \u00fczeri olarak \u00f6ng\u00f6r\u00fclmekte olup, bu %350\u2019den fazla potansiyel y\u00fckseli\u015f anlam\u0131na gelir."},{"question":"Yeni ba\u015flayan biri Geron hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, dolar maliyeti ortalamas\u0131 yaparak, stop-loss emirleri belirleyerek ve \u00f6nemli haberleri takip ederek yat\u0131r\u0131m yapmas\u0131 \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T10:53:57+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T10:53:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/\",\"name\":\"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-20T10:53:57+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T10:53:57+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T10:53:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/","name":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-20T10:53:57+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geron-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Geron Corporation (GERN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Geron Corporation (GERN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":340233,"slug":"how-to-buy-geron-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Geron Corporation (GERN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Geron Corporation (GERN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-geron-corporation\/"},"pt_AA":{"locale":"pt_AA","id":340228,"slug":"how-to-buy-geron-corporation","post_title":"Como comprar a\u00e7\u00f5es da Geron Corporation (GERN) - Investimento em a\u00e7\u00f5es da Geron Corporation (GERN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-geron-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=340230"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340230\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=340230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=340230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=340230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}